News search

    E.g., 12/09/2026
    E.g., 12/09/2026
    Anagha Jagannathan, Carlos Real Jiménez, Laura Cádiz, Sofía Trigo Anca, Anabel Díaz-Guerra Priego, Miguel Fernández Tocino, Carlos Galán Arriola, Borja Ibáñez, Agustín Clemente Moragón, Sandra Gomez, Ana Devesa, Juan Rene Delgado Cornejo, Danielle Medina-Hernandez, Warren Alexander Skoza, Lucía Pilar López Palomar, Nico Hoffmann, Carlos Caballero Henares and Ángela Pollán García.
    Research
    4 Feb 2025
    JACC CardioOncology: CNIC scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs

    The study, published in JACC: CardioOncology, shows that administration of the SGLT2 inhibitor empagliflozin to pigs receiving anthracyclines preserves mitochondrial function, improves myocardial energetics, and prevents degenerative changes in heart structure
    Gráfico explicativo
    Research
    20 Jan 2025
    The European mitochondrial lineage may protect against severe forms of COVID-19

    An international study led by Spanish research teams has identified how genetic factors can influence the severity of disease caused by SARS-CoV-2
    From left to right: D. MacGrogan, B. Flores-Garza, T. González-Costa, V. Sebastián-Serrano, J.L. de la Pompa, L. Méndez-Peralta, A. Pau-Navalón, A. Galicia-Martín, J. Santos-Cantador, C. Relaño-Ruperez, M. Siguero-Álvarez
    About the CNIC
    12 Dec 2024
    CNIC participates in an international Leducq Foundation project investigating the connection between the placenta and the heart during embryonic development

    The new project, ‘The Placenta in Maternal and Fetal Cardiovascular Health and Disease’, aims to understand how the placenta influences cardiovascular health in mothers and their children, promising improvements in the prevention and treatment of related diseases
    El Dr. Valentín Fuster recibe el Premio de la Sociedad Internacional de Aterosclerosis
    About the CNIC
    5 Dec 2024
    Valentin Fuster, wins prestigious award from the International Atherosclerosis Society

    The International Atherosclerosis Society recognizes the contributions to the understanding and treatment of atherosclerosis by the director of the National Center for Cardiovascular Research (CNIC) and president of the Mount Sinai Fuster Heart
    imagen
    About the CNIC
    23 Oct 2024
    JACARDI General Assembly: More than 200 experts from 21 European countries unite to improve care for cardiovascular disease and diabetes

    The National Center for Cardiovascular Research (CNIC), and the Health Research Institute of Hospital 12 de Octubre (i+12), representing SERMAS, are actively participating in JACARDI through different pilot projects
    imagen
    About the CNIC
    2 Oct 2024
    European Researchers’ Night 2024 at CNIC
    imagen
    About the CNIC
    30 Sep 2024
    CNIC Joins the 2024 Heart Race
    Vicente Andrés, Borja Ibáñez, Valentín Fuster, Ana García Álvarez, José Javier Fuster, Inés García Lunar, Antonio Quesada y Virginia Mass Ruiz.
    Research
    30 Sep 2024
    JACC: Progression of subclinical atherosclerosis predicts all-cause mortality risk

    A study published in The Journal of the American College of Cardiology (JACC) demonstrates that the burden and progression of silent atherosclerosis in

    Cardiovascular risk factors (particularly metabolic syndrome, insulin resistance, and diabetes) alter coronary microvascular function and increase the risk of atherosclerotic disease, which itself leads to changes in the coronary microcirculation.
    Research
    19 Sep 2024
    JACC: Cardiovascular Imaging: Cardiometabolic risk factors in apparently healthy individuals are linked to altered coronary microcirculation

    A study from CNIC reveals how risk factors and subclinical atherosclerosis affect heart microcirculation in asymptomatic middle-aged individuals. The research, published in JACC: Cardiovascular Imaging, highlights the importance of assessing the heart vessels' ability to regulate blood flow and predict future cardiovascular risk
    Figure
    Research
    13 Sep 2024
    The RESILIENCE trial: preventing heart injury caused by anticancer drugs

    RESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors